Strides Arcolab's net surges by 111% to Rs 11.58 in Q2 (PharmaBiz)
Strides Arcolab has notched up impressive growth in bottom line during the second quarter ended June 2007. Its consolidated net profit went up sharply by 111 per cent to Rs 11.58 crore from Rs 5.50 crore in the corresponding quarter of last year.

AspenBio Pharma Advances BoviPure FSH(TM) Reproduction Drug with FDA Filing and GMP Manufacturing Contract (PR Newswire via Yahoo! Finance)
AspenBio Pharma, Inc. an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, today reported that it has received its INADA file number for BoviPure FSH to officially start the United States Food and Drug Administration approval process.